Heparin-coated circuits reduce occult myocardial damage during CPB: A randomized, single blind clinical trial

European Journal of Cardio-thoracic Surgery

Volumn 17, Issue 5, 2000, Pages 580-586

  Belboul, Ali ^a,b   Löfgren, Christina ^b   Storm, Christina ^b   Jungbeck, Marie ^b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b Carlanderska Hospital   (Sweden)

Author keywords

Biocompatibility; Cardiac enzyme; Heart surgery; Heparin coated circuits; Lipid peroxidation

Indexed keywords

HEART ENZYME; HEPARIN; MALONALDEHYDE;

ADULT; AGED; ARTICLE; BIOCOMPATIBILITY; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL TRIAL; COMPLEMENT ACTIVATION; COMPLEMENT FACTOR; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HUMAN; LIPID PEROXIDATION; MALE; NEUTROPHIL; OPEN HEART SURGERY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE;

AGED; ASPARTATE AMINOTRANSFERASES; CARDIOPULMONARY BYPASS; COATED MATERIALS, BIOCOMPATIBLE; COMPLEMENT ACTIVATION; CORONARY ARTERY BYPASS; CREATINE KINASE; FEMALE; HEPARIN; HUMANS; ISOENZYMES; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; MIDDLE AGED; SINGLE-BLIND METHOD;

EID: 0343183931     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1010-7940(00)00392-4     Document Type: Article

References (20)

1. Chenoweth D.E., Cooper S.W., Hugli T.E., Stewart R.W., Blackstone E.H., Kirklin J.W. Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins. N Engl J Med. 304:1981;497-503.
2. Ashraf S., Butler J., Tian Y., Tian Y., Cowan D., Lintin S., Saunders N.R., Watterson K.G., Martin P.G. Inflammatory mediators in adults undergoing cardiopulmonary bypass: comparison of centrifugal and roller pumps. Ann Thorac Surg. 65:1998;480-484.
3. Bardenheuer H.J., Weigand M.A. Leukocyte endothelial interactions-a double edged sword. Cardiovasc Res. 41:1999;511-513.
4. Jansen P.G.M., te Velthuis H., Huybregts R.A., Paulus R., Bulder E.R., Van der Spoel H.I., Bezemer P.D., Slaats E.H., Eijsman L., Wildevuur C.R. Reduced complement activation and improved postoperative performance after cardiopulmonary bypass with heparin coated circuits. J Thorac Cardiovasc Surg. 110:1995;829-834.
5. Fingerle-Rowson G., Auers J., Kreuzer E., Labeta M., Schmidt B., Samtleben W., Zeigler-Heitbrock H.W.L., Blumenstein M. Down-regulation of surface monocyte lipopolysaccharide-receptor CD14 in patients on cardiopulmonary bypass undergoing aortocoronary bypass operations. J Thorac Cardiovasc Surg. 115:1998;1172-1178.
6. Gu Y.J., van Oeveren W., Akkerman C., Boonstra P.W., Huyzen R.J., Wildevuur C.R.H. Heparin-coated circuits reduce the inflammatory response to cardiopulmonary bypass. Ann Thorac Surg. 55:1993;917-922.
7. Redmond J.M., Gillinov A.M., Stuart R.S., Zehr K.J., Winkelstein J.A., Herskowitz A., Cameron D.E., Baumgarther W.A. Heparin-coated bypass circuits reduces pulmonary injury. Ann Thorac Surg. 56:1993;474-479.
8. Belboul A., Al-Khaja N., Gudmundsson M., Karlsson H., Uchino T., Liu B., El Gatit A., Bjelle A., Roberts D., William-Olsson G. The influence of heparin-coated and uncoated extracorporeal circulation on blood rheology during cardiac surgery. J ECT. 25:(2):1993;40-46.
9. Belboul A., Al-Khaja N. Does heparin coating improve biocompatibility? A study on complement, blood cells and postoperative morbidity during cardiac surgery. Perfusion. 12:1997;385-391.
10. Johnson D., Thomson D., Hurst T., Prasad K., Wilson T., Murphy F., Sezena A., Mayers I. Neutrophil-mediated acute lung injury after extracorporeal perfusion. J Thorac Cardiovasc Surg. 107:1994;1193-1202.
11. Asimkapoulus G. Mechanisms of the systemic inflammatory response. Perfusion. 14:1999;269-277.
12. Yagi K. Assay for blood plasma or serum. Methods Enzymol. 105:1984;328-331.
13. Asimakopoulus G., Taylor K.M. The effect of cardiopulmonary bypass on leukocyte and endothelial adhesion molecules. Ann Thorac Surg. 66:1998;2135-2144.
14. Shandelya S.M.L., Kuppusamy P., Weisfeldt M.L., Zweier J.L. Evaluation of polymorphonuclear leukocytes on contractile function in myocardial reperfusion injury: evidence for plasma-mediated leukocyte activation. Circulation. 87:1993;536-546.
15. Appleyard R.F., Cohn L.H. Myocardial stunning and reperfusion injury in cardiac surgery. J Card Surg. 8:1993;316-324.
16. Kusama Y., Bernier M., Hearse D.J. Singlet oxygen-induced arrythmias: Dose- and light-response studies for photoactivation of Rose Bengal in the rat heart. Circulation. 80:1989;1432-1448.
17. Bochenek A., Religa Z., Spyt T.J., Bochenek A.D., Zembala M., Grzybek H. Protective influence of pretreatment with allopurinol on myocardial function in patients undergoing coronary artery surgery. Eur J Cardio-thorac Surg. 4:1990;538-4542.
18. Breda M.A., Drinkwater D.C., Laks H., Bhuta S., Corno A.F., Davtyan H.G., Chang P. Prevention of reperfusion injury in the neonatal heart with leukocyte-depleted blood. J Thorac Cardiovasc Surg. 97:1989;654-665.
19. Zahler S., Massoudy P., Hartl H., Hähnel C., Meisner H., Becker B. Acute cardiac inflammatory responses to postischemic reperfusion during cardiopulmonary bypass. Cardiovasc Res. 44:1999;722-730.
20. Lazar H.L., Zhang X., Hamasaki T., Memmelo C., Treanor S.A., Shemin R.J. Heparin-bonded circuits decrease myocardial ischemic damage: an experimental study. Ann Thorac Surg. 63:1997;1701-1705.